Table 2.
Main characteristics and treatment modalities of patients with epithelial ovarian cancer undergoing FSS.
| Patient Characteristics | |
|---|---|
| Total n of patients | 3944 |
| Age (y), median (range) | 29 (23.5–36.5) |
| Tumor characteristics | n of patients (%) |
| FIGO stage | |
| IA | 912 (23.1) |
| IB | 9 (0.2) |
| IA/IB | 1154 (29.3) |
| IA/IC1 | 18 (0.5) |
| IC nos | 808 (20.5) |
| IC1 | 220 (5.6) |
| IC2 | 35 (0.9) |
| IC3 | 25 (0.6) |
| I nos | 9 (0.2) |
| ≥II | 646 (16.4) |
| na | 108 (2.7) |
| Histological subtype | |
| mucinous | 1775 (45.0) |
| endometrioid | 1059 (26.9) |
| serous | 760 (19.3) |
| clear cell | 287 (7.3) |
| mixed | 15 (0.4) |
| other/na | 48 (1.2) |
| Grade | |
| 1–2 | 3015 (76.4) |
| 2–3 | 6 (0.2) |
| 3 (+clear cell) | 855 (21.7) |
| 3 non-clear cell | 568 (14.4) |
| na | 68 (1.7) |
| Treatment modalities * | n/total (%) |
| Type of FSS | |
| staging | |
| Complete # | 776/1110 (69.9) |
| LND ^ | 617/1110 (55.6) |
| Surgical technique | |
| laparotomy | 275/426 (64.6) |
| laparoscopy | 151/426 (35.4) |
| Chemotherapy | |
| adjuvant | 1815/3586 (50.6) |
FSS—fertility-sparing surgery; LND—lymph node dissection; nos—not otherwise specified; na—not available; * limited to publications with available data; # unilateral salpingo-oophorectomy or cystectomy, cytology, biopsies, and omentectomy; ^ pelvic and/or para-aortic.